Global (R)-Duloxetine (CAS 116539-60-7) market was valued at USD 1.87 billion in 2025 and is projected to reach USD 3.64 billion by 2034, exhibiting a remarkable CAGR of 6.8% during the forecast period.  (R)-Duloxetine (CAS 116539-60-7) is the pharmacologically active enantiomer of duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI) widely used in the treatment of major...

The pursuit of "remission" rather than just "management" is the new North Star for researchers in the field of CIDP. Advanced proteomics and genomic sequencing are allowing researchers to identify specific biomarkers that can predict a patient's response to various therapies. This shift toward precision medicine is reducing the "trial and error" phase of treatment, which is often frustrating...

The Asia Pacific non-invasive radiosurgery robots market is experiencing rapid growth due to the increasing demand for advanced cancer treatment technologies and the continuous modernization of healthcare infrastructure across the region. Non-invasive radiosurgery robots are highly sophisticated systems used for delivering precise radiation therapy to tumors and other targeted...

The Alzheimer’s disease diagnostic professional market is witnessing significant growth due to the increasing prevalence of neurodegenerative disorders, rising aging populations, and growing awareness regarding early disease detection. Healthcare systems across the world are increasingly focusing on improving diagnostic accuracy and accelerating treatment intervention for patients...

The growing prevalence of bile duct cancer and the increasing demand for advanced oncology treatments are significantly contributing to the expansion of the global therapeutics market. Rising investments in cancer research, improved diagnostic technologies, and the introduction of targeted therapies are transforming the treatment landscape for cholangiocarcinoma, commonly known as bile duct...

According to a report by Intel Market Research, the global cancer treatment drugs market was valued at USD 193.12 billion in 2024 and is projected to grow from USD 211.45 billion in 2025 to USD 359.83 billion by 2032, exhibiting a CAGR of 9.5% during the forecast period. The market is witnessing strong growth due to the rising global burden of cancer, increasing adoption of targeted therapies...

Chemiluminescence imaging systems have emerged as indispensable tools in life sciences research, offering highly sensitive detection capabilities for biomolecules such as proteins and nucleic acids.  Market Trends and Growth AnalysisThe Chemiluminescence Imaging System Market Scope reflects significant expansion opportunities driven by increasing demand for advanced research tools and...

Bioinformatics Market Growth Dynamics and Emerging Trends The Bioinformatics Market Growth Dynamics are being shaped by increasing demand for precision medicine and personalized healthcare solutions. MRFR reports emphasize that organizations are leveraging AI and machine learning to manage complex datasets, improve clinical research efficiency, and accelerate drug development. Rising adoption...

The endonucleases market is experiencing robust growth as advancements in molecular biology, genetic engineering, and biotechnology continue to transform healthcare and life sciences research. Endonucleases are enzymes that cleave nucleic acid strands at specific internal sites, making them essential tools for DNA manipulation, gene editing, cloning, sequencing, and genome analysis. Their...

The epigenetic technologies market is witnessing remarkable growth as researchers and healthcare organizations increasingly focus on understanding gene regulation mechanisms and their impact on disease development. Epigenetics has emerged as a critical area of life science research, offering insights into how environmental factors and cellular processes influence gene expression without...